Evidence map›Paper›PMID 40341524›Full record

SynthesisNature communications2025

Chromatin state origins of uterine leiomyoma.

Maritta Räisänen, Eevi Kaasinen, Maija Jäntti, Aurora Taira, Emma Siili, Ralf Bützow, Oskari Heikinheimo, Annukka Pasanen, Auli Karhu, FinnGen and 3 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Maritta RäisänenDepartment of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-2764-0433
Eevi KaasinenDepartment of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-1333-8049
Maija JänttiDepartment of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.
Aurora TairaDepartment of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-1179-8500
Emma SiiliDepartment of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Ralf BützowApplied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.
Oskari HeikinheimoDepartment of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID http://orcid.org/0000-0002-8671-130X
Annukka PasanenDepartment of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Auli KarhuDepartment of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-7927-0796
FinnGen
Davide G BertaDepartment of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.
Niko VälimäkiDepartment of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0001-9200-9560
Lauri A AaltonenDepartment of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland. lauri.aaltonen@helsinki.fi.ORCID http://orcid.org/0000-0001-6839-4286

Funding

Academy of Finland (Suomen Akatemia) 319083Academy of Finland (Suomen Akatemia) 320149Academy of Finland (Suomen Akatemia) 352814Sigrid Juséliuksen Säätiö (Sigrid Jusélius Foundation) 230002Wellcome Trust 220001
6 · The paper itself

Abstract

Aberrations in the regulatory genome play a pivotal role in population-level disease predisposition. Annotation of the regulatory regions using appropriate primary tissues - instead of cell lines affected by selection and other confounding factors - could shed new light into mechanisms underlying common conditions. We test this approach in uterine leiomyomas, highly prevalent benign neoplasms of the myometrium, by creating 15-state chromatin annotations for myometrium and uterine leiomyomas. Integration with RNA-seq, ATAC-seq, HiChIP and methylation data enables us to compare the epigenomes of myometrium and ULs with distinct driver mutations, highlighting the role of bivalent regions in the neoplastic process. Subsequently, a genome wide association study meta-analysis is performed, using three different cohorts. Disease association loci are enriched at active chromatin, especially at enhancers, and harbor tumor- and driver mutation-specific chromatin states. At SATB2 locus we show the effect of the risk genotype already in the normal tissue. Integration of genome-wide association studies and deep regulatory genomics data from the correct tissue type represents a powerful approach in understanding population-level disease predisposition.

Indexed as

ChromatinLeiomyomaUterine NeoplasmsDNA MethylationEpigenomeFemaleGene Expression Regulation, NeoplasticGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMatrix Attachment Region Binding ProteinsMutationMyometriumTranscription FactorsChromatinMatrix Attachment Region Binding ProteinsSATB2 protein, humanTranscription Factors

Identifiers

PMID40341524
PMCPMC12062214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.